Regional differences in cortical dendrite morphology following in utero exposure to cocaine

Developmental Brain Research

Volumn 147, Issue 1-2, 2003, Pages 59-66

  Lloyd, Steven A ^a,b   Wensley, Beth ^a,c   Faherty, Ciaran J ^a   Smeyne, Richard J ^a  

^a Jude Children's Research Hospital   (United States)

^b Univ of TN Health Sciences Center   (United States)

^c University of Bath   (United Kingdom)

Author keywords

Cocaine; Cortical dendrite morphology; In utero exposure

Indexed keywords

COCAINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CHEMICAL PARAMETERS; CONTROLLED STUDY; DENDRITE; EMBRYO; FEMALE; FRONTAL CORTEX; GOLGI STAIN; MONOAMINE NERVE CELL; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SOMATOSENSORY CORTEX; TISSUE DIFFERENTIATION; TISSUE DISTRIBUTION;

MURINAE;

EID: 1642575209     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.devbrainres.2003.09.008     Document Type: Article

References (41)

1. Berger B., Verney C., Gay M., Vigny A. Immunocytochemical characterization of the dopaminergic and noradrenergic innervation of the rat neocortex during early ontogeny. Prog. Brain Res. 58:1983;263-267.
2. Berger B., Verney C., Alvarez C., Vigny A., Helle K.B. New dopaminergic terminal fields in the motor, visual (area 18b) and retrosplenial cortex in the young and adult rat. Immunocytochemical and catecholamine histochemical analyses. Neuroscience. 15:1985;983-998.
3. Berger M.A., Defagot M.C., Villar M.J., Antonelli M.C. D4 dopamine and metabotropic glutamate receptors in cerebral cortex and striatum in rat brain. Neurochem. Res. 26:2001;345-352.
4. Bradberry C.W. Dynamics of extracellular dopamine in the acute and chronic actions of cocaine. Neuroscientist. 8:2002;315-322.
5. Cases O., Vitalis T., Seif I., De Maeyer E., Sotelo C., Gaspar P. Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron. 16:1996;297-307.
6. Dow-Edwards D., Mayes L., Spear L., Hurd Y. Cocaine and development: clinical, behavioral, and neurobiological perspectives - a symposium report. Neurotoxicol. Teratol. 21:1999;481-490.
7. Essman W.D., Singh A., Lucki I. Serotonergic properties of cocaine: effects on a 5-HT2 receptor-mediated behavior and on extracellular concentrations of serotonin and dopamine. Pharmacol. Biochem. Behav. 49:1994;107-113.
8. Faherty C.J., Kerley D., Smeyne R.J. A Golgi-Cox morphological analysis of neuronal changes induced by environmental enrichment. Dev. Brain Res. 141:2003;55-61.
9. Gaspar P., Bloch B., Le Moine C. D1 and D2 receptor gene expression in the rat frontal cortex: cellular localization in different classes of efferent neurons. Eur. J. Neurosci. 7:1995;1050-1063.
10. Gressens P., Kosofsky B.E., Evrard P. Cocaine-induced disturbances of corticogenesis in the developing murine brain. Neurosci. Lett. 140:1992;113-116.
11. Hadfield M.G. Cocaine. Selective regional effects on central monoamines. Mol. Neurobiol. 11:1995;47-53.
12. Jones L., Fischer I., Levitt P. Nonuniform alteration of dendritic development in the cerebral cortex following prenatal cocaine exposure. Cereb. Cortex. 6:1996;431-445.
13. Jones L.B., Stanwood G.D., Reinoso B.S., Washington R.A., Wang H.Y., Friedman E., Levitt P. In utero cocaine-induced dysfunction of dopamine D1 receptor signaling and abnormal differentiation of cerebral cortical neurons. J. Neurosci. 20:2000;4606-4614.
14. Kosofsky B.E. Cocaine-induced alterations in neuro-development. Semin. Speech Lang. 19:1998;109-121.
15. Kosofsky B.E., Wilkins A.S., Gressens P., Evrard P. Transplacental cocaine exposure: a mouse model demonstrating neuroanatomic and behavioral abnormalities. J. Child Neurol. 9:1994;234-241.
16. Lauder J.M. Neurotransmitters as growth regulatory signals: role of receptors and second messengers. Trends Neurosci. 16:1993;233-240.
17. Lee F.J., Xue S., Pei L., Vukusic B., Chery N., Wang Y., Wang Y.T., Niznik H.B., Yu X.M., Liu F. Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell. 111:2002;219-230.
18. Levitt P., Harvey J.A., Friedman E., Simansky K., Murphy E.H. New evidence for neurotransmitter influences on brain development. Trends Neurosci. 20:1997;269-274.
19. Lidow M.S. Prenatal cocaine exposure adversely affects development of the primate cerebral cortex. Synapse. 21:1995;332-341.
20. Lidow M.S. Cocaine abuse and corticogenesis. Trends Neurosci. 21:1998;19-20.
21. Lidow M.S., Song Z.M. Primates exposed to cocaine in utero display reduced density and number of cerebral cortical neurons. J. Comp. Neurol. 435:2001;263-275.
22. Lidow M.S., Wang F. Neurotransmitter receptors in the developing cerebral cortex. Crit. Rev. Neurobiol. 9:1995;395-418.
23. Lipton S.A., Kater S.B. Neurotransmitter regulation of neuronal outgrowth, plasticity and survival. Trends Neurosci. 12:1989;265-270.
24. Mayes L.C. Developing brain and in utero cocaine exposure: effects on neural ontogeny. Dev. Psychopathol. 11:1999;685-714.
25. Meyer J.S., Shearman L.P., Collins L.M. Monoamine transporters and the neurobehavioral teratology of cocaine. Pharmacol. Biochem. Behav. 55:1996;585-593.
26. (NIDA) N.I.D.A., National pregnancy and health survey: drug use among women delivering live. 1992;NIDA, Bethesda, MD.
27. Ohtani N., Goto T., Waeber C., Bhide P.G. Dopamine modulates cell cycle in the lateral ganglionic eminence. J. Neurosci. 23:2003;2840-2850.
28. Pal R., Eaton M.J., Islam S., Hake-Frendscho M., Kumar K.N., Michaelis E.K. Immunocytochemical and in situ hybridization studies of the expression and distribution of three subunits of a complex with N-methyl-D-aspartate receptor-like properties. Neuroscience. 94:1999;1291-1311.
29. Parent A. Carpenter's Human Neuroanatomy. 9th ed. 1996;Williams and Wilkins, Baltimore.
30. Parnavelas J.G. The origin and migration of cortical neurones: new vistas. Trends Neurosci. 23:2000;126-131.
31. Paxinos G., Franklin K. The Mouse Brain in Stereotaxic Coordinates. 2nd ed. 2001;Academic Press, San Diego.
32. Reinoso B.S., Undie A.S., Levitt P. Dopamine receptors mediate differential morphological effects on cerebral cortical neurons in vitro. J. Neurosci. Res. 43:1996;439-453.
33. Robinson T.E., Kolb B. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci. 11:1999;1598-1604.
34. Robinson T.E., Gorny G., Mitton E., Kolb B. Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse. 39:2001;257-266.
35. Sholl D.A. Dendritic organization in the neurons of the visual and motor cortices of the cat. J. Anat. 87:1953;387-406.
36. Stanwood G.D., Levitt P. The effects of cocaine on the developing nervous system. Nelson C.A., Luciana M. Handbook of Developmental Cognitive Neuroscience. 2001;519-536 MIT Press, Cambridge, MA.
37. Stanwood G.D., Washington R.A., Shumsky J.S., Levitt P. Prenatal cocaine exposure produces consistent developmental alterations in dopamine-rich regions of the cerebral cortex. Neuroscience. 106:2001;5-14.
38. Streit P. Glutamate and aspartate as transmitter candidates for systems of the cerebral cortex. Jones E.G., Peters A. Cerebral Cortex. vol. 2:1984;119-143 Plenum, New York.
39. Wang J., O'Donnell P. D(1) dopamine receptors potentiate nmda-mediated excitability increase in layer V prefrontal cortical pyramidal neurons. Cereb. Cortex. 11:2001;452-462.
40. Wang H.Y., Runyan S., Yadin E., Friedman E. Prenatal exposure to cocaine selectively reduces D1 dopamine receptor-mediated activation of striatal Gs proteins. J. Pharmacol. Exp. Ther. 273:1995;492-498.
41. Wilkins A.S., Marota J.J., Tabit E., Kosofsky B.E. Transplacental cocaine exposure: 3. Mechanisms underlying altered brain development. Neurotoxicol. Teratol. 20:1998;239-249.